Related references
Note: Only part of the references are listed.Issues in Long-term Opioid Therapy: Unmet Needs, Risks, and Solutions
Steven D. Passik
MAYO CLINIC PROCEEDINGS (2012)
The Relationship Between Source of Diversion and Prescription Drug Misuse, Abuse, and Dependence
Jason A. Ford et al.
SUBSTANCE USE & MISUSE (2011)
Food Effects on the Pharmacokinetics of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules
Franklin Johnson et al.
ADVANCES IN THERAPY (2010)
Abuse-Deterrent and Tamper-Resistant Opioid Formulations What is their Role in Addressing Prescription Opioid Abuse?
Jennifer P. Schneider et al.
CNS DRUGS (2010)
Opioid Formulations Designed to Resist/Deter Abuse
Robert B. Raffa et al.
DRUGS (2010)
Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD
Rachel E. Dew et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Complications of Oral Exposure to Fentanyl Transdermal Delivery System Patches
Jane M. Prosser et al.
JOURNAL OF MEDICAL TOXICOLOGY (2010)
Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Joseph Stauffer et al.
CLINICAL DRUG INVESTIGATION (2009)
Nonmedical Use of Prescription Medications: An Emerging Risk Behavior Among Rural Adolescents
Sara B. Levine et al.
JOURNAL OF ADOLESCENT HEALTH (2009)
Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse
D. R. Jasinski et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Ethanol-Drug Absorption Interaction: Potential for a Significant Effect on the Plasma Pharmacokinetics of Ethanol Vulnerable Formulations
Hans Lennernas
MOLECULAR PHARMACEUTICS (2009)
A Difficult Balance - Pain Management, Drug Safety, and the FDA
Janet Woodcock
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Update on Abuse-Resistant and Abuse-Deterrent Approaches to Opioid Formulations
Lynn Webster
PAIN MEDICINE (2009)
Niacin use and cutaneous flushing: Mechanisms and strategies for prevention
Michael H. Davidson
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Abuse-deterrent opioid formulations: Are they a pipe dream?
Nathaniel Katz
Current Rheumatology Reports (2008)
Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release
Yaxin Lu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Do formulation differences alter abuse liability of methylphenidate? - A placebo-controlled, randomized, double-blind, crossover study in recreational drug users
Dolly A. Parasrampuria et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Challenges in the development of prescription opioid abuse-deterrent formulations
Nathaniel P. Katz et al.
CLINICAL JOURNAL OF PAIN (2007)
Simultaneous and concurrent polydrug use of alcohol and prescription drugs: Prevalence, correlates, and consequences
Sean Esteban McCabe et al.
JOURNAL OF STUDIES ON ALCOHOL (2006)
Ephemeral profiles of prescription drug and formulation tampering: Evolving pseudoscience on the Internet
EJ Cone
DRUG AND ALCOHOL DEPENDENCE (2006)
Trends in abuse of OxyContin® and other opioid analgesics in the United States:: 2002-2004
TJ Cicero et al.
JOURNAL OF PAIN (2005)
Mechanisms of neurotransmitter release by amphetamines: A review
D Sulzer et al.
PROGRESS IN NEUROBIOLOGY (2005)
Regulating opioid prescribing through prescription monitoring programs: Balancing drug diversion and treatment of pain
SM Fishman et al.
PAIN MEDICINE (2004)
The distinctiveness of ionic and nonionic bitter stimuli
ME Frank et al.
PHYSIOLOGY & BEHAVIOR (2004)
Share Paper
